| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.1 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |